Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/7/2025

Management of Gallbladder Polyps

Risk Classification and Management

  • Gallbladder polyps should be managed according to a risk-stratified approach based on size, morphology, and patient risk factors, with cholecystectomy recommended for polyps ≥10 mm and conservative management for smaller polyps with low-risk features 1, 2
  • Pedunculated polyps with "ball-on-the-wall" configuration or thin stalk are considered extremely low risk 1, 3
  • No follow-up is needed for polyps ≤9 mm with low-risk features 2, 4
  • Follow-up ultrasound at 6, 12, and 24 months is recommended for polyps 10-14 mm 2, 3
  • Surgical consultation is recommended for polyps ≥15 mm 2, 3

Diagnostic Approach

  • Optimize ultrasound technique with proper patient preparation (fasting) 1, 2
  • If technically inadequate, repeat ultrasound within 1-2 months 1, 2
  • For polyps ≥10 mm where differentiation from tumefactive sludge or adenomyomatosis is challenging, contrast-enhanced ultrasound (CEUS) is preferred if available 6

Special Considerations

  • Patients with Primary Sclerosing Cholangitis (PSC) have significantly higher risk of malignancy in gallbladder polyps (18-50%) 7
  • Consider cholecystectomy for polyps ≥8 mm in PSC patients 4

Risk Factors for Malignancy

  • Size ≥10 mm is the strongest predictor of malignancy 1
  • Sessile morphology is a risk factor for malignancy 7, 3
  • Primary sclerosing cholangitis is a risk factor for malignancy 7, 4
  • Rapid growth (≥4 mm within 12 months) is a risk factor for malignancy 2
  • Focal wall thickening adjacent to polyp is a risk factor for malignancy 2, 5